Literature DB >> 707131

Pharmacokinetics of clomethiazole in healthy adults.

K G Jostell, S Agurell, L G Allgén, B Kuylenstierna, J E Lindgren, G Aberg, G Osterlöf.   

Abstract

The systemic availability of clomethiazole was assessed by comparing blood levels after intravenous and oral administration. Clomethiazole was rapidly absorbed after oral administration to volunteers, particularly when administered as syrup. The fraction of the given dose that reached the systemic circulation after 1 capsule of clomethiazole (192 mg clomethiazole) was 0.25 +/- 0.18, after 2 capsules (384 mg clomethiazole) 0.38 +/- 0.18, and after 15 ml syrup (480 mg clomethiazole) 0.42 +/- 0.20. The time-blood concentration profiles were consistent with a two-compartment open model and the mean elimination half-lives of 3.6--5.0 hrs. were found for the different formulations and administration routes. Elimination half-lives showed little variation and a mean systemic clearance of 49 ml/min./kg was found for clomethiazole after intravenous administration. Clomethiazole is bound to human plasma proteins (63.4 +/- 1.6%, 37 degrees), a binding which is not affected by Vacutainer sample tubes. The blood/plasma distribution of clomethiazole was 0.76 +/- 0.02 at 37 degrees. A sensitive mass fragmentographic assay for the determination of clomethiazole in blood/plasma down to levels of 1 ng/ml (6.2 nmol/l) is described.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 707131     DOI: 10.1111/j.1600-0773.1978.tb02253.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


  7 in total

1.  Confusion and hypnotics in demented patients.

Authors:  M G Mead; C M Castleden
Journal:  J R Coll Gen Pract       Date:  1982-12

2.  Pharmacokinetics of chlormethiazole in healthy volunteers and patients with cirrhosis of the liver.

Authors:  P J Pentikäinen; P J Neuvonen; K G Jostell
Journal:  Eur J Clin Pharmacol       Date:  1980-04       Impact factor: 2.953

3.  Sorption of chlormethiazole by intravenous infusion giving sets.

Authors:  S E Tsuei; R L Nation; J Thomas
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

4.  Pharmacokinetics and sedative effects in healthy subjects and subjects with impaired liver function after continuous infusion of clomethiazole.

Authors:  Carina Centerholt; Marianne Ekblom; Tomas Odergren; Olof Borgå; Gabriela Popescu; Karl-Heinz Molz; Andrea Couturier; Angelika Weil
Journal:  Eur J Clin Pharmacol       Date:  2003-05-07       Impact factor: 2.953

5.  Direct measurement of chlormethiazole extraction by liver, lung and kidney in man.

Authors:  L E Mather; W B Runciman; A H Ilsley; K R Thomson; A R Goldin
Journal:  Br J Clin Pharmacol       Date:  1981-09       Impact factor: 4.335

6.  An integrated study of pharmacokinetics and pharmacodynamics of chlormethiazole in healthy young volunteers.

Authors:  L T Seow; L E Mather; J G Roberts
Journal:  Eur J Clin Pharmacol       Date:  1981-03       Impact factor: 2.953

7.  Improved hypnotic treatment using chlormethiazole and temazepam.

Authors:  R S Briggs; C M Castleden; C A Kraft
Journal:  Br Med J       Date:  1980-03-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.